Cepham’s Luteye Centers on Cellular Senescence to Protect Aging Eyes
May 01, 2024 08:30 ET
|
Cepham
Cepham announces the launch of Luteye to combat the effects of aging on eyes.
IPG Photonics Announces First Quarter 2024 Financial Results
April 30, 2024 08:00 ET
|
IPG Photonics Corporation
Delayed E-mobility Investments and Soft Industrial Demand Negatively Impacted Results Strong Operating Cash Flow Benefited from Working Capital Management MARLBOROUGH, Mass., April 30, 2024 ...
IPG Photonics Announces Leadership Transition
April 30, 2024 08:00 ET
|
IPG Photonics Corporation
Mark Gitin Appointed Next Chief Executive Officer and to Board of Directors Co-Founder Dr. Eugene Scherbakov to Remain a Member of the Board MARLBOROUGH, Mass., April 30, 2024 (GLOBE NEWSWIRE) --...
SEMCAP Buys Into the Next Phase of ALOHA's Growth, Investing Nearly $70 Million For a Significant Minority Stake
March 26, 2024 09:00 ET
|
SEMCAP Food & Nutrition; ALOHA
SEMCAP Food & Nutrition Invests $68 Million for significant majority stake in plant-based protein brand ALOHA.
LightSolver LPU100 Laser Computing System Empowers Enterprises to Solve the Toughest Optimization Problems
March 19, 2024 08:00 ET
|
LIGHTSOLVER LTD
LightSolver launches the LPU100 via the cloud to solve the toughest optimization problems, challenging the processing times of quantum and supercomputers.
Bitcoin Well Provides Preliminary Year End Update and Bitcoin Super Company Vision
February 21, 2024 08:35 ET
|
Bitcoin Well
Preliminary, unaudited Q4 growth numbers for Bitcoin Well and Bitcoin Super Company vision outline.
ONL Therapeutics to Present at 2024 BIO CEO & Investor Conference
February 06, 2024 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 06, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO)
February 01, 2024 01:03 ET
|
F. Hoffmann-La Roche Ltd
Vabysmo sustained robust drying of retinal fluid, often associated with distorted or blurry vision Up to 60% of people receiving Vabysmo were able to extend treatment intervals to three or four months...
IPG Photonics to Announce Fourth Quarter 2023 Financial Results on February 13
January 30, 2024 08:00 ET
|
IPG Photonics Corporation
MARLBOROUGH, Mass., Jan. 30, 2024 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP) will release its fourth quarter 2023 financial results before the market opens on Tuesday, February 13,...
ONL Therapeutics to Present on ONL1204 in Podium Presentation at the 47th Annual Meeting of the Macula Society
January 23, 2024 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...